Related references
Note: Only part of the references are listed.The role for autophagy in cancer
Eileen White
JOURNAL OF CLINICAL INVESTIGATION (2015)
Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
Suganthi Chittaranjan et al.
CLINICAL CANCER RESEARCH (2014)
Involvement of p38 in signal switching from autophagy to apoptosis via the PERK/eIF2α/ATF4 axis in selenite-treated NB4 cells
Q. Jiang et al.
CELL DEATH & DISEASE (2014)
Phosphorylated AKT inhibits the apoptosis induced by DRAM-mediated mitophagy in hepatocellular carcinoma by preventing the translocation of DRAM to mitochondria
K. Liu et al.
CELL DEATH & DISEASE (2014)
The anti-tumor efficiency of pterostilbene is promoted with a combined treatment of Fas signaling or autophagy inhibitors in triple negative breast cancer cells
Wei-Chih Chen et al.
FOOD & FUNCTION (2014)
Systemic treatment strategies for triple-negative breast cancer
Budhi Singh Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?
Roxana Chiorean et al.
BREAST (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T
Cornelia Braicu et al.
JOURNAL OF DRUG TARGETING (2013)
Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells
Cornelia Braicu et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2013)
p53siRNA therapy reduces cell proliferation, migration and induces apoptosis in triple negative breast cancer cells
Cornelia Braicu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
Rebecca Johnson et al.
Pharmaceutics (2013)
(-)-Epigallocatechin-3-Gallate Induces Apoptosis and Inhibits Invasion and Migration of Human Cervical Cancer Cells
Chhavi Sharma et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
The rebel angel: mutant p53 as the driving oncogene in breast cancer
Dawid Walerych et al.
CARCINOGENESIS (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells
Fujun Dai et al.
PLOS ONE (2012)
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma
Chun-Ann Chen et al.
CANCER BIOLOGY & THERAPY (2008)
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
Jose G. Teodoro et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
DRAM, a p53-induced modulator of autophagy, is critical for apoptosis
Diane Crighton et al.
CELL (2006)
Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial
IA Atencio et al.
CANCER GENE THERAPY (2006)
Share Paper
